Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 02, 2026 242.45M
October 01, 2026 245.93M
September 30, 2026 249.95M
September 29, 2026 253.76M
September 28, 2026 263.60M
September 25, 2026 259.45M
September 24, 2026 257.58M
September 23, 2026 259.52M
September 22, 2026 266.41M
September 21, 2026 263.87M
September 18, 2026 265.34M
September 17, 2026 268.28M
September 16, 2026 265.74M
September 15, 2026 266.68M
September 14, 2026 270.42M
September 11, 2026 266.01M
September 10, 2026 267.75M
September 09, 2026 266.28M
September 08, 2026 268.42M
September 04, 2026 265.34M
September 03, 2026 267.88M
September 02, 2026 275.24M
September 01, 2026 269.35M
August 31, 2026 266.14M
August 28, 2026 269.22M
Date Value
August 27, 2026 265.74M
August 26, 2026 276.98M
August 25, 2026 273.23M
August 24, 2026 272.43M
August 21, 2026 278.32M
August 20, 2026 272.43M
August 19, 2026 271.36M
August 18, 2026 275.51M
August 17, 2026 274.17M
August 14, 2026 274.57M
August 13, 2026 270.16M
August 12, 2026 281.67M
August 11, 2026 270.96M
August 10, 2026 263.60M
August 07, 2026 273.50M
August 06, 2026 256.64M
August 05, 2026 243.66M
August 04, 2026 249.28M
August 03, 2026 264.33M
July 31, 2026 244.86M
July 30, 2026 228.67M
July 29, 2026 203.24M
July 28, 2026 189.59M
July 27, 2026 187.85M
July 24, 2026 186.91M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
Precigen, Inc. 3.118B
Repligen Corp. 10.13B
Amgen, Inc. 261.20B
Biogen, Inc. 39.55B
BioMarin Pharmaceutical, Inc. 14.41B